Trial Profile
Effect of candesartan on recurrence of esophageal varices after endoscopic therapy with hypertension.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Aug 2014
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Calcium channel antagonists
- Indications Hypertension
- Focus Pharmacodynamics
- 16 Aug 2014 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record UMIN000002088 .
- 24 Jun 2009 New trial record